American Cyanamid
Executive Summary
Purchases 6% of Techniclone International (400,000 shares) for $ 1.2 mil. Proceeds will be used to fund R&D of TNT antibodies, which may be useful for imaging cancer tumors. American Cynamic has option to fund human studies and acquire exclusive marketing rights for the antibodies which will be manufactured by Techniclone International.